Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture
- 1 June 2000
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 14 (9), 1287-9
- https://doi.org/10.1097/00002030-200006160-00034
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitorsAIDS, 1999
- Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export ProteinsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1999
- Human Immunodeficiency Virus Protease Inhibitors Serve as Substrates for Multidrug Transporter Proteins MDR1 and MRP1 but Retain Antiviral Efficacy in Cell Lines Expressing These TransportersAntimicrobial Agents and Chemotherapy, 1998
- Interaction of Anti-HIV Protease Inhibitors With the Multidrug Transporter P-Glycoprotein (P-gp) in Human Cultured CellsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug TransporterBiochemistry, 1998
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.JCI Insight, 1998
- The physiological function of drug-transporting P-glycoproteinsSeminars in Cancer Biology, 1997
- P-glycoprotein and multidrug resistanceCurrent Opinion in Genetics & Development, 1996
- Multidrug transporter p‐glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during agingAmerican Journal of Hematology, 1995
- P-Glycoprotein Expression and RegulationDrugs & Aging, 1995